If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...

The programme – spearheaded by The Academic Respiratory Initiative for Pulmonary Health (Tariph) Centre under LKCMedicine – ...

“Preventing unnecessary exposure to air pollution and consistently wearing masks in high-risk environments can significantly ...

Study reveals the Prospector calculator reduces antibiotic prescriptions in COPD exacerbations, improving outcomes and ...

Tezepelumab did not significantly decrease moderate or severe COPD exacerbations compared with placebo, the COURSE trial found.

Globally, COPD is also a leading cause of death. Data from the World Health Organization in 2021 ranked it as the fourth ...

Respiratory disease testing companies are Koninklijke Philips N.V., Niterra., Thermo Fisher Scientific, QIAGEN, Abbott, Danaher Corp, Siemens Healthineers, etc ...

Therapies to treat IPF are limited ... and cellular interactions in distinct cell populations in chronic obstructive pulmonary disease ...

Chronic lower respiratory diseases, including chronic obstructive pulmonary disease (COPD), are the sixth leading cause of ...

Computational research conducted by scientists from Washington University in St. Louis shows that GLP-1 agonists can have ...

Walking, or atypical, pneumonia, is a mild form of pneumonia that often resembles a cold. You may not have a high fever and ...

Aerobic exercise and a bath are part of columnist Caroline Gainer's evening routine, which helps her manage COPD and get ...